[go: up one dir, main page]

FI970393L - (-)-(3R)-3-metyyli-4-(4-(4-(4-pyridyyli)piperatsin-1-yyli)fenoksi)voihappo soluadheesioinhibiittoreina - Google Patents

(-)-(3R)-3-metyyli-4-(4-(4-(4-pyridyyli)piperatsin-1-yyli)fenoksi)voihappo soluadheesioinhibiittoreina Download PDF

Info

Publication number
FI970393L
FI970393L FI970393A FI970393A FI970393L FI 970393 L FI970393 L FI 970393L FI 970393 A FI970393 A FI 970393A FI 970393 A FI970393 A FI 970393A FI 970393 L FI970393 L FI 970393L
Authority
FI
Finland
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
FI970393A
Other languages
English (en)
Swedish (sv)
Other versions
FI970393A0 (fi
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI970393A0 publication Critical patent/FI970393A0/fi
Publication of FI970393L publication Critical patent/FI970393L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI970393A 1995-06-01 1997-01-30 (-)-(3R)-3-metyyli-4-(4-(4-(4-pyridyyli)piperatsin-1-yyli)fenoksi)voihappo soluadheesioinhibiittoreina FI970393L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (2)

Publication Number Publication Date
FI970393A0 FI970393A0 (fi) 1997-01-30
FI970393L true FI970393L (fi) 1997-01-30

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970393A FI970393L (fi) 1995-06-01 1997-01-30 (-)-(3R)-3-metyyli-4-(4-(4-(4-pyridyyli)piperatsin-1-yyli)fenoksi)voihappo soluadheesioinhibiittoreina

Country Status (31)

Country Link
EP (1) EP0796247A1 (fi)
JP (1) JP2885941B2 (fi)
KR (1) KR100245957B1 (fi)
AT (1) AT406675B (fi)
AU (1) AU710105B2 (fi)
BE (1) BE1009520A5 (fi)
BR (1) BR9606409A (fi)
CA (1) CA2194397A1 (fi)
CH (1) CH691808A5 (fi)
CZ (1) CZ26997A3 (fi)
DE (1) DE19680509T1 (fi)
DK (1) DK10697A (fi)
ES (1) ES2137886B1 (fi)
FI (1) FI970393L (fi)
GB (1) GB2304340B (fi)
GR (1) GR1002702B (fi)
HU (1) HUP9700274A3 (fi)
IE (1) IE960405A1 (fi)
IL (1) IL118477A0 (fi)
IT (1) IT1290839B1 (fi)
LU (1) LU90008B1 (fi)
MC (1) MC2418A1 (fi)
MX (1) MX9700379A (fi)
NL (1) NL1003243C2 (fi)
NO (1) NO307460B1 (fi)
NZ (1) NZ308597A (fi)
PL (1) PL318440A1 (fi)
SE (1) SE510812C2 (fi)
SK (1) SK13097A3 (fi)
TR (1) TR199700020T1 (fi)
WO (1) WO1996038416A1 (fi)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
DK0825184T3 (da) * 1993-03-29 2001-09-10 Astrazeneca Ab Heterocykliske derivater som blodpladeaggregeringsinhibitorer

Also Published As

Publication number Publication date
ES2137886B1 (es) 2000-08-16
FI970393A0 (fi) 1997-01-30
IL118477A0 (en) 1996-09-12
ATA900596A (de) 1999-12-15
HUP9700274A2 (hu) 1999-06-28
TR199700020T1 (tr) 1997-04-22
SK13097A3 (en) 1997-08-06
EP0796247A1 (en) 1997-09-24
AU5827296A (en) 1996-12-18
NZ308597A (en) 1998-11-25
NO970437D0 (no) 1997-01-31
ES2137886A1 (es) 1999-12-16
HU9700274D0 (en) 1997-04-28
NO970437L (no) 1997-02-20
GR1002702B (el) 1997-05-22
NL1003243C2 (nl) 1996-12-04
JPH09512836A (ja) 1997-12-22
GB2304340A (en) 1997-03-19
WO1996038416A1 (en) 1996-12-05
BE1009520A5 (fr) 1997-04-01
DK10697A (da) 1997-04-01
AT406675B (de) 2000-07-25
AU710105B2 (en) 1999-09-16
BR9606409A (pt) 1997-09-30
DE19680509T1 (de) 1997-12-04
HUP9700274A3 (en) 2000-02-28
ITMI961113A0 (it) 1996-05-31
SE9700203D0 (sv) 1997-01-24
NO307460B1 (no) 2000-04-10
CH691808A5 (de) 2001-10-31
SE510812C2 (sv) 1999-06-28
CA2194397A1 (en) 1996-12-05
GB2304340B (en) 1998-07-29
CZ26997A3 (en) 1997-08-13
IT1290839B1 (it) 1998-12-14
MC2418A1 (fr) 1997-05-23
MX9700379A (es) 1997-04-30
LU90008B1 (fr) 1997-04-16
IE960405A1 (en) 1996-12-11
PL318440A1 (en) 1997-06-09
KR970704689A (ko) 1997-09-06
KR100245957B1 (ko) 2000-04-01
GB9627127D0 (en) 1997-02-19
SE9700203L (sv) 1997-01-24
JP2885941B2 (ja) 1999-04-26
ITMI961113A1 (it) 1997-12-01

Similar Documents

Publication Publication Date Title
DE19680255T1 (de) Inhibitoren der Enzymaktivität von Rotamase
NO974213L (no) Små-molekylære inhibitorer for rotamase-enzym-aktivitet
DE69522690D1 (de) alpha-ketogultarsäure dehydrogenasegen
DE69637328D1 (de) Zelladhäsionsinhibitoren
FI973087L (fi) Soluadheesion inhibiittoreita
DK199901518A (da) I form af små molekyler foreliggende inhibitorer af rotamase-enzymaktivitet
NO990338D0 (no) Celleadhesjonsinhibitorer
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
EE9800125A (et) Rotamaasse ensümaatilise aktiivsuse inhibiitorid
ID27840A (id) Turunan-turunan asam hidroksi pipekolat hidroksamat sebagai inhibitor-inhibitor mmp
FI973282A0 (fi) Trombiinin inhibiittoreita
ATE239755T1 (de) Thrombin inhibitoren
EE9900180A (et) Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
FI970393A0 (fi) (-)-(3R)-3-metyyli-4-(4-(4-(4-pyridyyli)piperatsin-1-yyli)fenoksi)voihappo soluadheesioinhibiittoreina
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
NO965353D0 (no) 3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer
KR970000223A (ko) 콜레스테롤 생합성 저해제